SYT7是增加外体分泌和促进非小细胞肺癌血管生成的关键参与者
Xiao Liu1, Rui Li1, Xiao Chen2
1Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China.
Cancer letters
|September 29, 2023
概括
合成素7 (SYT7) 通过增强外体细胞分泌促进非小细胞肺癌 (NSCLC) 转移. 这项研究揭示了SYT7的存在.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因之一,之前与其转移有关的是synaptotagmin 7 (SYT7).
- SYT7在癌症特异性外体分泌中的作用及其更广泛的胰腺癌特征在很大程度上仍未被描述.
研究的目的:
- 进行SYT7的综合性胰腺癌分析,包括其表达,诊断和预后价值,遗传改变,甲基化,免疫透和相关途径.
- 阐明SYT7在调节瘤外体分泌中的功能及其对血管生成和NSCLC进展的影响.
主要方法:
- 在各种癌症类型中对SYT7进行瘤分析.
- 使用NSCLC细胞系 (A549,H1299) 的体外实验来评估SYT7对外体分泌和内皮细胞功能的影响.
- 在小鼠模型中进行体内研究,以评估SYT7在瘤发生,血管生成和转移中的作用.
主要成果:
- SYT7增强NSCLC细胞的外体分泌,促进人静脉内皮细胞 (HUVECs) 的迁移,增殖和管形成.
- 通过55kDa (CEP55) 的中心体蛋白的外体转移,SYT7促进血管生成,激活mTOR信号通路,促进NSCLC的入侵和转移.
- SYT7上调合成素-1a和合成素-3以促进外体的分泌,驱动瘤发生,血管发生和体内转移.
结论:
- SYT7是NSCLC中外体分泌的关键调节者,通过CEP55/mTOR途径驱动瘤进展,血管新生和转移.
- 准SYT7及其外体介导途径为NSCLC提供了潜在的治疗策略.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mechanism of Angiogenesis
5.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


